EP3436463
CRYSTALLINE FORMS OF 2-[(2S)-1-AZABICYCLO[2.2.2]OCT-2-YL]-6-(3-METHYL-1H- PYRAZOL-4-YL)THIENO[3,2-D]PYRIMIDIN-4(3H)-ONE HEMIHYDRATE
:
EP einkaleyfi: Þýðing ekki lögð inn:
27.3.2017:
23.6.2021:
17719053.5
:
26.3.2037
:
CRYSTALLINE FORMS OF 2-[(2S)-1-AZABICYCLO[2.2.2]OCT-2-YL]-6-(3-METHYL-1H- PYRAZOL-4-YL)THIENO[3,2-D]PYRIMIDIN-4(3H)-ONE HEMIHYDRATE
27.3.2017
23.6.2021
:
Takeda Pharmaceutical Company Limited:
1-1 Doshomachi 4-chome Chuo-ku, Osaka-shi, Osaka 541-0045, JP
:
IWATA, Kentaro:
Fujisawa Kanagawa 251-0012, JP
:
MIZUNO, Masahiro:
Yodogawa-ku Osaka-shi 532-0024, JP
:
MAEDA, Kazuhiro:
Yodogawa-ku Osaka-shi 532-0024, JP
:
YASUMA, Tsuneo:
Yodogawa-ku Osaka-shi 532-0024, JP
:
HOMMA, Misaki:
Fujisawa 251-0012, JP
:
OGURO, Yuya:
Fujisawa 251-0012, JP
:
TAYA, Naohiro:
Fujisawa 251-0012, JP
:
ZHU, Lei:
Bedford, MA 01730, US
:
BAILEY, John, Daniel:
Boston, MA 02128, US
:
LANGSTON, Marianne:
Cambridge, MA 02139, US
:
PATIL, Siddhesh, Dinanath:
Cambridge, MA 02138, US
:
GOUR, Shruti:
Watertown, MA 02472, US
:
ROY, Lilly:
Boston, MA 02108, US
:
201662314080 P:
28.3.2016:
US
:
201662367842 P:
28.7.2016:
US
:
US2017024226:
27.3.2017
:
C07D 495/04, A61P 35/00, A61P 35/02, A61P 43/00